资讯

National Institute for Health and Care Excellence10 小时
In consultation: Guidance and quality standards
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer [ID6339] Draft guidance Technology appraisal guidance 2 June 2025 Metabolic Dysfunction-Associated ...